Heart surgery patients test easier blood thinner
NCT ID NCT07434661
Summary
This study aims to see if a newer blood thinner (Apixaban) is as safe and effective as the standard one (Warfarin) for patients with atrial fibrillation in the first three months after biological heart valve repair or replacement surgery. It will involve 120 patients who have recently had this type of heart surgery. The goal is to determine if the newer medication, which doesn't require frequent blood tests, can work just as well to prevent strokes and dangerous clots during this critical recovery period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
"E.Meshalkin National Medical Research Center" of the Ministry of Health of the Russian Federation
Novosibirsk, Russia
Conditions
Explore the condition pages connected to this study.